(Q44493980)

English

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

scientific article published in July 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

0 references

author name string

Melanie S Joy

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

William F Finn

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

LAM-302 Study Group

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

American Journal of Kidney Diseases

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

96-107

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900554-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900554-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Aluminium-induced anaemia in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900554-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The dialysis encephalopathy syndrome. Possible aluminum intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900554-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900554-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900554-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900554-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900554-7

7 January 2021

based on heuristic

inferred from DOI database lookup

RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900554-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900554-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900554-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Elemental analysis in normal and cataractous human lens tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900554-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0272-6386(03)00554-7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44493980&oldid=2025706130"